The Inflation Reduction Act of 2022 will raise taxes, increase spending, and prolong both inflation and the recession.
Senators Need to Check Their Conscience Before Voting for Price Controls
Senators must understand that price controls will harm patients and reduce the development of future cures.
Subcommittee Hearing Tries to Shed Light on COVID-19 Relief Fraud
The government’s abject failure to prevent COVID fraud shows the risks of hasty and reckless spending.
The Human Cost of Pharmaceutical Price Controls is Too High
Price controls will result in the loss of life due to a lack of future research and development.
Price Controls Are Still Bad Medicine
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
The Senate Must Reject Price Controls on Pharmaceuticals
Senators should reject price controls on pharmaceuticals; they will not lower prices and lead to fewer future cures.
The Senate Should Not Implement Price Controls on Pharmaceuticals
Price controls on pharmaceuticals will not lower prices and will lead to fewer future cures.
President Biden Again Tries to Undermine U.S. Biomedical Innovation
President Biden’s support of intellectual property waivers threatens development of future life-saving medicines.
Transparency is Needed Before More COVID-19 Aid is Approved
Congress and the rest of the federal government must increase transparency for taxpayers
Price Controls in the BBBA Will Destroy the Development of Future Cures
The price controls found in the BBBA leave patients worse off.